미국의 호흡용 DME 시장 규모, 점유율, 동향 분석 보고서 : 제품 제공별, 유통 및 서비스 채널별, 주요주별, 부문별 예측(2026-2033년)

U.S. Respiratory Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product Offering, By Distribution & Service Channel, By Notable States, And Segment Forecasts, 2026 - 2033

US $ 4,250 ￦ 6,415,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 5,250 ￦ 7,924,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 7,250 ￦ 10,943,000

Printable PDF & Excel (Enterprise License)

PDF & Excel 보고서를 동일 기업(자회사 포함)의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다. 인쇄물의 이용 범위는 파일의 이용 범위와 동일합니다.

한글목차

미국의 호흡용 DME 시장 요약

미국의 호흡용 DME 시장 규모는 2025년에 40억 1,000만 달러로 평가되며, 2033년까지 58억 9,000만 달러에 달할 것으로 예측됩니다.

2026-2033년 연평균 4.93% 성장할 것으로 예측됩니다. 이러한 성장은 작고 효율적인 휴대용 산소발생기, 개선된 비침습적 재택 인공호흡기, 연결형 PAP 장치의 기술적 진보에 기인합니다.

또한 중서부 지역의 만성 호흡기 질환(특히 COPD 및 관련 동반 질환)의 높은 유병률, 고령의 메디케어 가입자가 많은 인구 구성, 재택 진료를 선호하는 대규모 지방 환자군의 존재는 농축기, 휴대용 산소 시스템, 가정용 인공호흡기에 대한 지속적인 수요를 창출하고 있습니다. 수요가 지속적으로 발생하고 있습니다. 중서부 지역에서는 만성폐쇄성폐질환(COPD), 천식, 수면호흡장애 등 만성 호흡기 질환의 발병률이 상대적으로 높은데, 이는 주로 고령화와 특정 지역의 높은 흡연율에 기인합니다.

미국 폐협회에 따르면 2023년 기준 미국내 약 1,110만 명의 성인이 COPD를 앓고 있으며, 이는 여전히 이환율과 사망률의 주요 원인으로 연간 약 500억 달러의 의료비용이 소요될 것으로 추정됩니다. COPD 환자들의 고탄산혈증, 급성 악화, 수면 중 호흡장애를 관리하기 위해 비침습적 인공호흡기가 필요함에 따라 재택 및 병원용 BiPAP/VPAP 장비에 대한 수요가 증가하고 있습니다.

오하이오, 미시간, 인디애나, 일리노이, 미주리 등의 주에서는 COPD 및 폐쇄성 수면무호흡증(OSA)의 유병률이 매우 높아 산소발생기, CPAP/BiPAP 장치, 분무기, 환기 보조 장비 수요를 직접적으로 지원하고 있습니다. 또한 고령화가 진행되는 지역 특성상 퇴원 후 장기적인 호흡 보조 및 급성기 이후 케어 장비를 필요로 하는 노인이 증가함에 따라 이들 장비의 도입이 가속화되고 있습니다.

또한 중서부 지역의 의료 시스템, 병원, 보험사에서는 재택 치료와 비용 절감을 강조하고 있으며, 입원 기간 단축과 재입원 페널티를 피하기 위해 호흡기 치료가 입원 환경에서 재택 환경으로 적극적으로 전환되고 있습니다. 이로 인해 장기 산소 요법, 수면 치료 장비, 원격 환자 모니터링 기능이 있는 호흡 장비에 대한 DME 프로바이더에 대한 의존도가 높아지고 있습니다. 이러한 추세는 특히 중서부 지역의 대부분을 차지하는 지방 및 준도시 지역에서 재택 산소 요법 및 수면 요법의 사용을 촉진하는 메디케어-메디케이드의 상환 구조에 의해 촉진되고 있습니다. 또한 중서부 지역은 메디케어 수혜자 비율이 상대적으로 높기 때문에 연방 정부의 상환 정책이 호흡기 DME 수요의 중요한 견인차 역할을 하고 있습니다.

예를 들어 네브래스카주의 지불자 패턴은 도시와 농촌이 혼합된 호흡기 관련 특성을 반영하고 있으며, PAP 장비는 메디케이드에 편중되어 있습니다. 이는 수면무호흡증후군의 발생률이 65세 이상 연령층보다 비고령층에서 더 높기 때문인 것으로 분석됩니다. 메디케어도 여전히 큰 비중을 차지하지만, 주로 고령의 COPD 환자층을 대상으로 하므로 보조적인 위치에 있습니다. 한편, 산소발생기, 인공호흡기, 분무기는 메디케어 의존도가 매우 높은데, 이는 네브래스카주의 고령화되는 COPD 및 만성 호흡기 질환 환자층이 연방정부의 노인 보험에 의존하고 있는 현실과 일치합니다. 민간보험의 점유율이 낮은 이유는 지방의 기업보험 보급률이 낮기 때문입니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 미국의 호흡용 DME 시장 : 제품 제공별 추정·동향 분석

제4장 미국의 호흡용 DME 시장 : 유통·서비스 채널 추정·동향 분석

제5장 지역/주 레벨 : 부문별, 2021-2033년

제6장 경쟁 분석

KSA

영문 목차

영문목차

U.S. Respiratory Durable Medical Equipment Market Summary

The U.S. respiratory durable medical equipment (DME) market size was valued at USD 4.01 billion in 2025 and is projected to reach USD 5.89 billion by 2033, growing at a CAGR of 4.93% from 2026 to 2033. This growth is attributed to the technological advances smaller, more efficient portable oxygen concentrators, improved non-invasive home ventilators and connected PAP machines.

In addition, higher chronic respiratory disease prevalence (notably COPD and related comorbidities) in many Midwestern states together with an older, Medicare-heavy population and large rural patient cohorts who prefer home-based care, creates enduring demand for concentrators, portable oxygen systems and home ventilators. The Midwest has a comparatively higher prevalence of chronic respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and sleep-disordered breathing, largely due to an aging population and higher smoking prevalence in certain states.

According to the American Lung Association, in 2023, approximately 11.1 million adults in the United States are living with COPD, which remains a leading cause of morbidity and mortality and is associated with an estimated USD 50 billion in annual healthcare costs. The increasing burden of COPD, combined with the need for non-invasive ventilation to manage hypercapnia, acute exacerbations, and sleep-disordered breathing in these patients, has fueled demand for home and hospital-based BiPAP/VPAP devices.

States such as Ohio, Michigan, Indiana, Illinois, and Missouri report a significant burden of COPD and obstructive sleep apnea (OSA), directly supporting demand for oxygen concentrators, CPAP/BiPAP devices, nebulizers, and ventilatory support equipment. The region's aging demographic profile further accelerates adoption, as older adults are more likely to require long-term respiratory support and post-acute care equipment following hospital discharge.

Moreover, the strong emphasis on home-based care and cost containment across Midwestern healthcare systems, hospitals, and payers is actively shifting respiratory care from inpatient to home settings to reduce length of stay and readmission penalties, increasing reliance on DME providers for long-term oxygen therapy, sleep therapy devices, and remote patient monitoring-enabled respiratory equipment. This trend is fueled by Medicare and Medicaid reimbursement structures, which incentivize home oxygen and sleep therapy utilization, particularly in rural and semi-urban areas that characterize much of the Midwest. In addition, the Midwest has a relatively high proportion of Medicare beneficiaries, making federal reimbursement policies a critical demand driver for respiratory DME volumes.

For instance, Nebraska's payer pattern reflects a mixed urban-rural respiratory profile, where PAP devices tilt toward Medicaid because sleep apnea incidence is higher in the adult, non-elderly population than in the 65+ group. Medicare still contributes substantially but remains secondary as its coverage primarily captures older COPD-dominant cohorts. However, oxygen concentrators, ventilators, and nebulizers lean strongly toward Medicare, consistent with Nebraska's aging COPD and chronic respiratory population that relies more on federal senior coverage. Private plans track smaller shares due to lower employer-sponsored penetration in rural counties.

U.S. Respiratory Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. respiratory durable medical equipment (DME) market report based on product offerings, distribution & service channel, and Midwest states:

• Product Offerings Outlook (Revenue, USD Million, 2021 - 2033)
• Sleep Apnea Devices
  • Auto-titrating CPAP (APAP)
  • Fixed CPAP
  • BiPAP / VPAP
  • Integrated Humidifiers
• Oxygen Therapy
  • Stationary Oxygen Concentrators
  • Portable Oxygen Concentrators (POCs)
  • Cylinders & Regulators
  • Conservers
• Nebulizer Equipment
  • Compressor Nebulizers
  • Mesh Nebulizers
  • Drug-specific nebulizers
• Home & Transport Ventilators
  • Adult/pediatric long-term home ventilators
  • Portable Transport Ventilators
• Masks, Tubing, Filters & Resupply Items (Consumables)
  • CPAP masks
  • CPAP cushions
  • Oxygen tubing & filters
  • Humidifier chambers
  • Bacterial/viral filters
  • Aerosol delivery accessories
• Distribution & Service Channel Outlook (Revenue, USD Million, 2021 - 2033)
• National DME Networks
• Regional Independents
• Hospital/IDN Homecare Extensions
• Online DME Retailers
• Notable States (Midwest Only) Outlook (Revenue, USD Million, 2021 - 2033)
• Nebraska (NE)
• Iowa (IA)
• Kansas (KS)
• South Dakota (SD)
• North Dakota (ND)
• Missouri (MO)
• Minnesota (MN)
• Wisconsin (WI)
• Illinois (IL)
• Colorado (CO)
• Wyoming (WY)
• Ohio (OH)
• Indiana (IN)

Table of Contents

Chapter 1 Research Methodology and Scope

• 1.1 Market Segmentation & Scope
  • 1.1.1 Regional Scope
  • 1.1.2 Estimates And Forecast Timeline
• 1.2 Objectives
  • 1.2.1 Objective - 1
  • 1.2.2 Objective - 2
  • 1.2.3 Objective - 3
• 1.3 List of Secondary Sources
• 1.4 List of Abbreviation

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Product and End Use Outlook
• 2.3 Competitive Landscape

Chapter 3 U.S. Respiratory Durable Medical Equipment Market: Product Offering Estimates & Trend Analysis

• 3.1 U.S. Respiratory Durable Medical Equipment Market: Product Offering Segment Dashboard
• 3.2 Product Offering Movement & Market Share Analysis, 2024 & 2033
• 3.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Product Offering
  • 3.3.1 Sleep Apnea Devices
    • 3.3.1.1 Sleep Apnea Devices Market, 2021 - 2033 (USD Million)
    • 3.3.1.2 Auto-titrating CPAP
    • 3.3.1.3 Fixed CPAP
    • 3.3.1.4 BiPAP/VPAP (S/T, AVAPS)
    • 3.3.1.5 Integrated Humidifiers
  • 3.3.2 Oxygen Therapy
    • 3.3.2.1 Oxygen Therapy Market, 2021 - 2033 (USD Million)
    • 3.3.2.2 Stationary Oxygen Concentrators
    • 3.3.2.3 Portable Oxygen Concentrators (POCs)
    • 3.3.2.4 Cylinders & regulators
    • 3.3.2.5 Conservers
  • 3.3.3 Nebulizer Therapy Equipment
    • 3.3.3.1 Nebulizer Therapy Equipment Market, 2021 - 2033 (USD Million)
    • 3.3.3.2 Compressor nebulizers
    • 3.3.3.3 Mesh Nebulizers
    • 3.3.3.4 Drug-specific Nebulizers
  • 3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 3.3.4.1 Masks, Tubing, Filters & Resupply Items (Consumables) Market, 2021 - 2033 (USD Million)
    • 3.3.4.2 CPAP Masks & Cushions
    • 3.3.4.3 Oxygen tubing & filters
    • 3.3.4.4 Humidifier Chambers
    • 3.3.4.5 Bacterial/Viral (B/V)
    • 3.3.4.6 Aerosol Delivery Accessories
  • 3.3.5 Home & Transport Ventilators
    • 3.3.5.1 Home & Transport Ventilatorsmarket, 2021 - 2033 (USD Million)
    • 3.3.5.2 Adult/Pediatric Long-Term Home Ventilators
    • 3.3.5.3 Portable Ventilators (Transport/ALS)

Chapter 4 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Estimates & Trend Analysis

• 4.1 U.S. Respiratory Durable Medical Equipment Market: Distribution & Service Channels Segment Dashboard
• 4.2 Distribution & Service Channels Movement & Market Share Analysis, 2024 & 2033
• 4.3 U.S. Respiratory Durable Medical Equipment Market Size Estimates & Forecast, by Distribution & Service Channels
  • 4.3.1 National Dme Networks
    • 4.3.1.1 National DME Networks market, 2021 - 2033 (USD Million)
  • 4.3.2 Regional Independents
    • 4.3.2.1 Regional Independents Market, 2021 - 2033 (USD Million)
  • 4.3.3 Hospital/Idn Homecare Extensions
    • 4.3.3.1 Hospital/IDN Homecare Extensions Market, 2021 - 2033 (USD Million)
  • 4.3.4 Online Dme Retailers
    • 4.3.4.1 Online DME Retailers Market, 2021 - 2033 (USD Million)

Chapter 5 Regional/State-Level Quantified Deliverables, by Segment, 2021 - 2033, (Revenue, USD Million)

• 5.1 Midwest
  • 5.1.1 Nebraska
    • 5.1.1.1 Nebraska Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.1.2 Demand & Patient Population
      • 5.1.1.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.1.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.1.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.1.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.1.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.1.3 Supplier Density & Network Mapping
    • 5.1.1.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.1.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.1.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.1.5.1 Sleep Clinics
      • 5.1.1.5.2 Pulmonologists
      • 5.1.1.5.3 Hospitals
      • 5.1.1.5.4 Other providers
    • 5.1.1.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.1.7 Research Methodology
  • 5.1.2 IOWA
    • 5.1.2.1 Iowa Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.2.2 Demand & Patient Population
      • 5.1.2.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.2.2.2 Utilization and healthcare service demand metrics, by sleep apnea devices
      • 5.1.2.2.3 Utilization and healthcare service demand metrics, by nebulizers equipment
      • 5.1.2.2.4 Utilization and healthcare service demand metrics, by home & transport ventilators
      • 5.1.2.2.5 Utilization and healthcare service demand metrics, by oxygen therapy
    • 5.1.2.3 Supplier Density & Network Mapping
    • 5.1.2.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.2.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.2.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.2.5.1 Sleep Clinics
      • 5.1.2.5.2 Pulmonologists
      • 5.1.2.5.3 Hospitals
      • 5.1.2.5.4 Other providers
    • 5.1.2.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.2.1 Research Methodology
  • 5.1.3 KANSAS
    • 5.1.3.1 Kansas Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.3.2 Demand & Patient Population
      • 5.1.3.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.3.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.3.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.3.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.3.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.3.3 Supplier Density & Network Mapping
    • 5.1.3.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.3.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.3.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.3.5.1 Sleep Clinics
      • 5.1.3.5.2 Pulmonologists
      • 5.1.3.5.3 Hospitals
      • 5.1.3.5.4 Other providers
    • 5.1.3.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.3.7 Research Methodology
  • 5.1.4 SOUTH DAKOTA
    • 5.1.4.1 South Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.4.2 Demand & Patient Population
      • 5.1.4.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.4.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.4.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.4.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.4.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.4.3 Supplier Density & Network Mapping
    • 5.1.4.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.4.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.4.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.4.5.1 Sleep Clinics
      • 5.1.4.5.2 Pulmonologists
      • 5.1.4.5.3 Hospitals
      • 5.1.4.5.4 Other providers
    • 5.1.4.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.4.7 Research Methodology
  • 5.1.5 North Dakota
    • 5.1.5.1 North Dakota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.5.2 Demand & Patient Population
      • 5.1.5.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.5.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.5.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.5.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.5.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.5.3 Supplier Density & Network Mapping
    • 5.1.5.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.5.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.5.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.5.5.1 Sleep Clinics
      • 5.1.5.5.2 Pulmonologists
      • 5.1.5.5.3 Hospitals
      • 5.1.5.5.4 Other providers
    • 5.1.5.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.5.7 Research Methodology
  • 5.1.6 Missouri
    • 5.1.6.1 Missouri Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.6.2 Demand & Patient Population
      • 5.1.6.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.6.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.6.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.6.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.6.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.6.3 Supplier Density & Network Mapping
    • 5.1.6.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.6.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.6.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.6.5.1 Sleep Clinics
      • 5.1.6.5.2 Pulmonologists
      • 5.1.6.5.3 Hospitals
      • 5.1.6.5.4 Other providers
    • 5.1.6.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.6.7 Research Methodology
  • 5.1.7 Minnesota
    • 5.1.7.1 Minnesota Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.7.2 Demand & Patient Population
      • 5.1.7.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.7.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.7.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.7.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.7.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.7.3 Supplier Density & Network Mapping
    • 5.1.7.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.7.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.7.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.7.5.1 Sleep Clinics
      • 5.1.7.5.2 Pulmonologists
      • 5.1.7.5.3 Hospitals
      • 5.1.7.5.4 Other providers
    • 5.1.7.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.7.7 Research Methodology
  • 5.1.8 Wisconsin
    • 5.1.8.1 Wisconsin Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.8.2 Demand & Patient Population
      • 5.1.8.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.8.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.8.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.8.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.8.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.8.3 Supplier Density & Network Mapping
    • 5.1.8.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.8.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.8.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.8.5.1 Sleep Clinics
      • 5.1.8.5.2 Pulmonologists
      • 5.1.8.5.3 Hospitals
      • 5.1.8.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.8.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.8.7 Research Methodology
  • 5.1.9 Illinois
    • 5.1.9.1 Illinois Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.9.2 Demand & Patient Population
      • 5.1.9.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.9.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.9.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.9.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.9.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.9.3 Supplier Density & Network Mapping
    • 5.1.9.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.9.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.9.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.9.5.1 Sleep Clinics
      • 5.1.9.5.2 Pulmonologists
      • 5.1.9.5.3 Hospitals
      • 5.1.9.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.9.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.9.7 Research Methodology
  • 5.1.10 Colorado
    • 5.1.10.1 Colorado Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.10.2 Demand & Patient Population
      • 5.1.10.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.10.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.10.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.10.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.10.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.10.3 Supplier Density & Network Mapping
    • 5.1.10.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.10.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.10.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.10.5.1 Sleep Clinics
      • 5.1.10.5.2 Pulmonologists
      • 5.1.10.5.3 Hospitals
      • 5.1.10.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.10.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.10.7 Research Methodology
  • 5.1.11 WYOMING
    • 5.1.11.1 Wyoming Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.11.2 Demand & Patient Population
      • 5.1.11.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.11.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.11.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.11.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.11.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.11.3 Supplier Density & Network Mapping
    • 5.1.11.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.11.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.11.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.11.5.1 Sleep Clinics
      • 5.1.11.5.2 Pulmonologists
      • 5.1.11.5.3 Hospitals
      • 5.1.11.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.11.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.11.7 Research Methodology
  • 5.1.12 OHIO
    • 5.1.12.1 Ohio Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.12.2 Demand & Patient Population
      • 5.1.12.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.12.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.12.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.12.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.12.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.12.3 Supplier Density & Network Mapping
    • 5.1.12.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.12.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.12.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.12.5.1 Sleep Clinics
      • 5.1.12.5.2 Pulmonologists
      • 5.1.12.5.3 Hospitals
      • 5.1.12.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.12.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.12.7 Research Methodology
  • 5.1.13 INDIANA
    • 5.1.13.1 Indiana Respiratory DME Market, 2021 - 2033 (USD Million)
    • 5.1.13.2 Demand & Patient Population
      • 5.1.13.2.1 Number of patients requiring respiratory DME devices by product category for the period 2021 - 2033
      • 5.1.13.2.2 Utilization and healthcare service demand metrics, By sleep apnea devices
      • 5.1.13.2.3 Utilization and healthcare service demand metrics, By nebulizers equipment
      • 5.1.13.2.4 Utilization and healthcare service demand metrics, By home & transport ventilators
      • 5.1.13.2.5 Utilization and healthcare service demand metrics, By oxygen therapy
    • 5.1.13.3 Supplier Density & Network Mapping
    • 5.1.13.4 Reimbursement & Payer Landscape (2024/2025)
      • 5.1.13.4.1 Breakdown of reimbursement rates and payer shares for the following payer categories, segmented by product category
    • 5.1.13.5 Referral & Clinical Ecosystem (2024/2025)
      • 5.1.13.5.1 Sleep Clinics
      • 5.1.13.5.2 Pulmonologists
      • 5.1.13.5.3 Hospitals
      • 5.1.13.5.4 Other providers (PCP, ENT, etc.)
    • 5.1.13.6 Regulatory & Licensing (Most recent updates to be included)
    • 5.1.13.7 Research Methodology

Chapter 6 Competitive Analysis

• 6.1 Participant's Overview
  • 6.1.1 Tier 1 (National DME Providers)
  • 6.1.2 Tier 2 (OEM Manufacturers)
  • 6.1.3 Tier 3 (Regional Independents)
• 6.2 Financial Performance
  • 6.2.1 Tier 1 (National DME Providers)
    • 6.2.1.1 Public Companies
    • 6.2.1.2 Private Companies
  • 6.2.2 Tier 2 (OEM Manufacturers)
    • 6.2.2.1 Public Companies
    • 6.2.2.2 Private Companies
  • 6.2.3 Tier 3 (Regional Independents)
    • 6.2.3.1 Private Companies
• 6.3 Product Benchmarking
  • 6.3.1 Tier 1 (National DME Providers)
    • 6.3.1.1 Sleep Apnea Devices
    • 6.3.1.2 Oxygen Therapy
      • 6.3.1.2.1 Portable Oxygen Concentrators
      • 6.3.1.2.2 Stationary Oxygen Concentrators
    • 6.3.1.3 Nebulizer Therapy Equipment
    • 6.3.1.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.1.5 Home & Transport Ventilators
  • 6.3.2 Tier 2 (OEM Manufacturers)
    • 6.3.2.1 Sleep Apnea Devices
    • 6.3.2.2 Oxygen Therapy
      • 6.3.2.2.1 Portable Oxygen Concentrators
      • 6.3.2.2.2 Stationary Oxygen Concentrators
    • 6.3.2.3 Nebulizer Therapy Equipment
    • 6.3.2.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.2.5 Home & Transport Ventilators
  • 6.3.3 Tier 3 (Regional Independents)
    • 6.3.3.1 Sleep Apnea Devices
    • 6.3.3.2 Oxygen Therapy
      • 6.3.3.2.1 Portable Oxygen Concentrators
      • 6.3.3.2.2 Stationary Oxygen Concentrators
    • 6.3.3.3 Nebulizer Therapy Equipment
    • 6.3.3.4 Masks, Tubing, Filters & Resupply Items (Consumables)
    • 6.3.3.5 Home & Transport Ventilators
• 6.4 Participant Categorization
• 6.5 Company Market Position Analysis
  • 6.5.1 Tier 1 (National DME Providers)
  • 6.5.2 Tier 2 (OEM Manufacturers)
  • 6.5.1 Tier 3 (Regional Independents)
• 6.6 Exit Strategies of Existing Market Players and Their Impact On Market Competitors
  • 6.6.1 Medical Depot, Inc. Dba Drive Devilbiss Healthcare
    • 6.6.1.1 Medical Depot, Inc. dba Drive DeVilbiss Healthcare's Exit Strategy Aims to Realign the Company with its Mission and Vision
    • 6.6.1.2 Entry of React Health following Medical Depot, Inc. dba Drive DeVilbiss Healthcare's exit and its anticipated impact
  • 6.6.2 Philips Respironics
    • 6.6.2.1 Philips Respironics Exit Strategy Stems from Regulatory Pressure, Reputational Impact, And Portfolio Realignment
  • 6.6.3 Fisher & Paykel Healthcare
    • 6.6.3.1 Exit Strategy of Fisher & Paykel Healthcare for F&P Sleep Style CPAP in the U.S.
  • 6.6.4 Invacare
    • 6.6.4.1 Invacare's Exit Strategy Aims to Realign the Company with Its Mission and Vision.
    • 6.6.4.2 Entry of React Health Following Invacare's Exit and Its Anticipated Impact
  • 6.6.5 Resmed
    • 6.6.5.1 ResMed's Exit Strategy from the Portable Oxygen Concentrator (POC) Market
  • 6.6.6 Medtronic
    • 6.6.6.1 Medtronic Exit Strategy
  • 6.6.7 Teleflex Incorporated
    • 6.6.7.1 Teleflex Incorporated Exit Strategy
  • 6.6.8 Breas Medical AB
    • 6.6.8.1 Breas Medical - Exit Strategy for Z1 & Z2 Series CPAP Devices
• 6.7 Strategy Mapping
  • 6.7.1 Tier 1 (National DME Providers)
    • 6.7.1.1 Mergers and Acquisitions
    • 6.7.1.2 Collaborations & Partnerships
  • 6.7.2 Tier 2 (OEM Manufacturers)
    • 6.7.2.1 New Product Launch
    • 6.7.2.2 Mergers and Acquisitions
    • 6.7.2.3 Other Strategies
  • 6.7.3 Tier 3 (Regional Independents)
    • 6.7.3.1 Mergers and Acquisitions
• 6.8 List of Other Market Players

관련자료